RxSight Light Adjustable Lens and Light Delivery Device
Rxsight, Inc. · Decision date Oct 22, 2026
What did the FDA decide?
The FDA record for P160055/S058 lists a 30-day notice with the decision code OK30, dated 2026-10-22, for RxSight, Inc.'s light adjustable lens (LAL) and light delivery device (LDD) product, product code PZK. The stated purpose is a manufacturing change: relocating the supplier manufacturing site for a critical raw precursor material used in LAL/LAL+ devices. The supplement reason field classifies this as a process change affecting manufacturer, sterilizer, packager or supplier.
The identifier ties S058 to PMA P160055; it is a supplement to that PMA, not a new approval of the LAL/LDD system as a whole, and a manufacturing notice is not the original PMA. The record describes a supplier-site relocation for one precursor material and does not report safety, clinical effectiveness, or performance data. It also does not name the supplier, the precursor material, the old or new site locations, or the scope of any testing, so those specifics remain unknown from the supplied fields.
FDA approval order statement
changing the location of supplier manufacturing site for a critical raw precursor material to LAL/LAL+ devices
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Ophthalmic
- Decision date
- Oct 22, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160055/S058
- Regulatory pathway
- PMA supplement
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- Decision code
- OK30
- Decision date
- Oct 22, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Light adjustable lens (LAL) and light delivery device (LDD).
- Applicant
- Rxsight, Inc.
- Product code
- PZK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160055. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160055 · Original PMA
LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)
P160055/S056 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
P160055/S058 received
Application receipt date recorded by FDA.
P160055/S058 · FDA decision
30-Day Notice
P160055/S057 · Related supplement
RxSight Light Adjustable Lens and Light Delivery Device
Timeline entries are records held by MedtechLedger for P160055. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160055
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Rxsight, Inc. | PMA approval | Nov 22, 2017 | FDA | |
| Rxsight, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
| Rxsight, Inc. | PMA supplement | Nov 5, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Rxsight, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 100 Columbia, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P160055/S058
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

